ADBiotech Co., Ltd. (KOSDAQ: A179530)
Health Care · Pharmaceuticals · KR
₩2,290.00
+11.44% today · -31.0% 1Y
ADBiotech Co., Ltd. (KOSDAQ: A179530) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $45.91M.
Over the last twelve months the share price has lost 31.0%, trading between 1.30K and 4.10K.
Tweenvest scores ADBiotech Co., Ltd. across four factors: quality 54/100, value 62/100. Its strongest factor is value.
A179530 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.91M
- Revenue (TTM)
- $8.12M
- P/E
- —
- EPS
- -207.76
- Dividend yield
- —
- Beta (5Y)
- 0.27
- 52-week high
- ₩4,100.00
- 52-week low
- ₩1,300.00
- Avg volume (3M)
- —
- Shares outstanding
- 26.95M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PharmGen Science, Inc.KOSE: A004720 | $48.11M | ₩2,860.00 | +0.35% |
| THX Pharma Société AnonymeENXTPA: ALTHX | $47.50M | €3.09 | +0.49% |
| AB Science S.A.ENXTPA: AB | $46.95M | €0.55 | +4.77% |
| Albert David LimitedBSE: 524075 | $46.62M | Rs790.65 | -7.10% |
| BioStem Technologies, Inc.NasdaqCM: BSEM | $45.90M | $2.47 | -9.52% |
| Pharmedic Pharmaceutical Medicinal Joint Stock CompanyHNX: PMC | $45.63M | ₫127,000.00 | +1.68% |
| Trident Lifeline LimitedBSE: 543616 | $45.62M | Rs370.00 | -1.69% |
| Vext Science, Inc.CNSX: VEXT | $45.14M | CA$0.26 | +15.56% |
Figures last refreshed Oct 11, 2026.